表紙:経鼻ドラッグデリバリー技術の市場規模、シェア、動向分析レポート:剤形別、容器タイプ別、治療用途別、流通チャネル別、地域別、セグメント別予測、2023年~2030年
市場調査レポート
商品コード
1178594

経鼻ドラッグデリバリー技術の市場規模、シェア、動向分析レポート:剤形別、容器タイプ別、治療用途別、流通チャネル別、地域別、セグメント別予測、2023年~2030年

Nasal Drug Delivery Technology Market Size, Share & Trends Analysis Report By Dosage Form, By Container Type, By Therapeutic Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 185 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
経鼻ドラッグデリバリー技術の市場規模、シェア、動向分析レポート:剤形別、容器タイプ別、治療用途別、流通チャネル別、地域別、セグメント別予測、2023年~2030年
出版日: 2022年12月12日
発行: Grand View Research
ページ情報: 英文 185 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経鼻ドラッグデリバリー技術市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の経鼻ドラッグデリバリー技術市場は2022年に1271億2000万米ドルとなり、2023年から2030年までCAGR7.45%で拡大しました。鼻腔用製品に関する認知度の高まりは、市場を牽引する主要な要因の1つとなっています。

老年人口の増加は、市場全体をポジティブに推進すると予想されます。国連経済社会局の報告書によると、2020年には、65歳以上の高齢者が世界で7億2,700万人いるとされています。今後30年間で、世界の高齢者数は2倍以上の成長を描き、2050年には15億人を超えると予想されています。2020年から2050年にかけて、老年人口は全国的に増加すると予想されています。世界的に見ると、65歳以上の高齢者の割合は、2020年の9.3%から2050年には16.0%近くまで上昇すると予想されています。

さらに、効能や投与のしやすさから経鼻製剤を好む患者が増加していることも、経鼻ドラッグデリバリーシステム市場の成長を後押しすると予想されます。例えば、2021年2月、フィンランドNanoform社とHerantis社は、製剤の概念実証の取り組みに関する非独占契約を締結し、脳への経鼻ドラッグデリバリーに関する合意を発表しています。

さらに、経鼻ドラッグデリバリー法は、薬物の全身循環経路、低いバイオアベイラビリティ、速い吸収、望ましい作用などを提供するため、脳疾患の治療に広く使用されています。この点で、経鼻ドラッグデリバリーは、中枢神経系薬剤の魅力的な非侵襲的送達方法として機能する可能性があります。さらに、ペプトイド、ラルチトレキセド、5-フルオロウラシルテロメラーゼ阻害剤、メトトレキセートなどの物質の鼻腔送達は、動物モデルにおいて脳腫瘍を減らし、生存率を高めることが示されています。

経鼻ドラッグデリバリー技術市場レポートハイライト

投与形態別では、感染症やアレルギー性鼻炎の発生率の増加、点鼻薬のジェネリック医薬品の需要増により、点鼻薬分野が2022年に最大の売上シェアを占めた

容器タイプ別では、2022年に非加圧容器セグメントが市場を独占しました。点鼻薬、点鼻パウダー、点鼻ジェルは通常これらの容器に入っています。関連製品の需要の高まりが、予測期間中のセグメントの成長を促進すると予想される

治療用途別では、鼻炎の治療に関連製品が利用できることから、2022年には鼻炎分野が最大のシェアを占めた

販売チャネル別では、入手のしやすさと利便性から、小売薬局向けが2022年に最大のシェアを獲得

喘息や慢性閉塞性肺疾患の有病率の上昇と早期治療法の普及により、2022年の市場シェアは北米が最も高い

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 剤形
    • コンテナの種類
    • 治療への応用
    • 流通経路
    • 地域範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査内容
      • 北米の一次面接データ
      • 欧州での一次面接のデータ
      • APACの一次インタビューのデータ
      • ラテンアメリカの一次面接のデータ
      • MEAでの一次インタビューのデータ
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析(モデル1)
      • アプローチ1:コモディティフローアプローチ
    • 出来高価格分析(モデル2)
      • アプローチ2:出来高価格分析
  • 二次情報一覧
  • 略語一覧
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し

第3章 経鼻ドラッグデリバリー技術市場の変数、動向、範囲

  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因分析
      • 経鼻薬ドラッグデリバリーに対する患者の嗜好の高まり
      • 慢性疾患の発生率の増加
      • 自己管理慣行の採用の増加
      • 呼吸器ケアのための特許切れ医薬品の開発
    • 市場抑制要因分析
      • 点鼻スプレーの過剰使用に伴う合併症
      • 厳格な規制の枠組み
  • 経鼻ドラッグデリバリー技術:市場分析ツール
    • PESTEL別SWOT分析
    • 業界分析- ポーターの5つの力
  • COVID-19の影響
    • COVID-19影響分析
    • 市場関係者への影響

第4章 経鼻ドラッグデリバリー技術市場:セグメント分析、剤形別、2018年から2030年(10億米ドル)

  • 定義と範囲
  • 剤形市場シェア分析
  • セグメントダッシュボード
  • 経鼻ドラッグデリバリー技術市場、投与形態別
  • 市場規模と予測、トレンド分析、2018年から2030年
    • 鼻スプレー
    • 点鼻薬
    • 鼻ジェル
    • 点鼻薬

第5章 経鼻ドラッグデリバリー技術市場:セグメント分析、容器タイプ別、2018年から2030年(10億米ドル)

  • 定義と範囲
  • コンテナタイプの市場シェア分析
  • セグメントダッシュボード
  • 経鼻ドラッグデリバリー技術市場、容器タイプ別
  • 市場規模と予測、トレンド分析、2018年から2030年
    • 加圧容器
    • 非加圧容器

第6章 経鼻ドラッグデリバリー技術市場:セグメント分析、治療用途別、2018年から2030年(10億米ドル)

  • 定義と範囲
  • 治療アプリケーションの市場シェア分析
  • セグメントダッシュボード
  • 経鼻ドラッグデリバリー技術市場、治療用途別
  • 市場規模と予測、トレンド分析、2018年から2030年
    • 鼻詰まり
    • 鼻炎
    • 喘息
    • その他

第7章 経鼻ドラッグデリバリー技術市場:セグメント分析、流通チャネル別、2018年から2030年(10億米ドル)

  • 定義と範囲
  • 流通チャネル市場シェア分析
  • セグメントダッシュボード
  • 経鼻ドラッグデリバリー技術市場、流通チャネル別
  • 市場規模と予測、トレンド分析、2018年から2030年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第8章 経鼻ドラッグデリバリー技術市場:地域市場分析、2018年から2030年(10億米ドル)

  • 地域市場ダッシュボード
  • 定義と範囲
  • 地域市場シェア分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 経鼻ドラッグデリバリー技術市場-競合分析

  • 競合の種類
  • 市場関係者の集中
  • 企業の市場シェア分析
  • 企業ビジョンに基づくカテゴライズ
  • 企業プロファイル
    • GlaxoSmithKline PLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • AstraZeneca PLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Pfizer, Inc.
      • 会社概要
      • 財務実績
      • 製品ベンチマーク
      • 戦略的イニシアチブ
    • OptiNose, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Becton, Dickinson and Company
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Promius Pharma, LLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Cadila Pharmaceuticals Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • BF Ascher &Company, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • PendoPharm, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Douglas Pharmaceuticals Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ENT Technologies Pty. Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ENT Technologies Pty. Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 4 North America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 5 North America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 6 North America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 7 U.S. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 8 U.S. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 9 U.S. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 11 Canada nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 12 Canada nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 13 Canada nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 14 Canada nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Europe nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 16 Europe nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 17 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 18 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 19 Europe nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 20 Germany nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 21 Germany nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 22 Germany nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 23 Germany nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 24 U.K. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 25 U.K. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 26 U.K. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 27 U.K. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 France nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 29 France nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 30 France nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 31 France nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 32 Italy nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 33 Italy nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 34 Italy nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 35 Italy nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 36 Spain nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 37 Spain nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Sweden nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 41 Sweden nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 42 Sweden nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 43 Sweden nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 44 Denmark nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 45 Denmark nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 46 Denmark nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 47 Denmark nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 48 Norway nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 49 Norway nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 50 Norway nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 51 Norway nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 54 Asia Pacific nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 55 Asia Pacific nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 56 Asia Pacific nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 57 China nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 58 China nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 59 China nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 60 China nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 61 Japan nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 62 Japan nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 63 Japan nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 64 Japan nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 India nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 66 India nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 67 India nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 68 India nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 69 Australia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 70 Australia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 71 Australia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 72 Australia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 73 South Korea nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 74 South Korea nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 75 South Korea nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 76 South Korea nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 77 Thailand nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 78 Thailand nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 79 Thailand nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 80 Thailand nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Latin America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 82 Latin America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 83 Latin America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 84 Latin America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 85 Latin America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 86 Brazil nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 87 Brazil nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 88 Brazil nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 89 Brazil nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 90 Mexico nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 91 Mexico nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 92 Mexico nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 93 Mexico nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Argentina nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 95 Argentina nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 96 Argentina nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 97 Argentina nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 98 Middle East and Africa nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 99 Middle East and Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 100 Middle East and Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 101 Middle East and Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 102 Middle East and Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 103 South Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 104 South Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 105 South Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 106 South Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 107 Saudi Arabia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 108 Saudi Arabia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 109 Saudi Arabia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 110 Saudi Arabia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 111 UAE nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 112 UAE nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 113 UAE nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 114 UAE nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 115 Kuwait nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 116 Kuwait nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 117 Kuwait nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 118 Kuwait nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Nasal drug delivery technology: market outlook
  • Fig. 14 Nasal drug delivery technology competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Nasal drug delivery technology driver impact
  • Fig. 20 Nasal drug delivery technology restraint impact
  • Fig. 21 Nasal drug delivery technology strategic initiatives analysis
  • Fig. 22 Nasal drug delivery technology: dosage form movement analysis
  • Fig. 23 Nasal drug delivery technology: dosage form outlook and key takeaways
  • Fig. 24 Nasal spray market estimates and forecast, 2018 - 2030
  • Fig. 25 Nasal drop market estimates and forecast, 2018 - 2030
  • Fig. 26 Nasal gel market estimates and forecast, 2018 - 2030
  • Fig. 27 Nasal powder market estimates and forecast, 2018 - 2030
  • Fig. 28 Nasal drug delivery technology: container type movement analysis
  • Fig. 29 Nasal drug delivery technology: container type outlook and key takeaways
  • Fig. 30 Pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 31 Non-pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 32 Nasal drug delivery technology: therapeutic application movement analysis
  • Fig. 33 Nasal drug delivery technology: therapeutic application outlook and key takeaways
  • Fig. 34 Nasal congestion market estimates and forecast, 2018 - 2030
  • Fig. 35 Rhinitis market estimates and forecast, 2018 - 2030
  • Fig. 36 Asthma market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Nasal drug delivery technology: distribution channel movement analysis
  • Fig. 39 Nasal drug delivery technology: distribution channel outlook and key takeaways
  • Fig. 40 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 41 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 43 Global nasal drug delivery technology market: regional movement analysis
  • Fig. 44 Global nasal drug delivery technology market: regional outlook and key takeaways
  • Fig. 45 Global market shares and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 65 U.K.
  • Fig. 66 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 67 Germany
  • Fig. 68 Germany market estimates and forecast, 2018 - 2030
  • Fig. 69 France
  • Fig. 70 France market estimates and forecast, 2018 - 2030
  • Fig. 71 Italy
  • Fig. 72 Italy market estimates and forecast, 2018 - 2030
  • Fig. 73 Spain
  • Fig. 74 Spain market estimates and forecast, 2018 - 2030
  • Fig. 75 Sweden
  • Fig. 76 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 79 Norway
  • Fig. 80 Norway market estimates and forecast, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 83 China
  • Fig. 84 China market estimates and forecast, 2018 - 2030
  • Fig. 85 Japan
  • Fig. 86 Japan market estimates and forecast, 2018 - 2030
  • Fig. 87 India
  • Fig. 88 India market estimates and forecast, 2018 - 2030
  • Fig. 89 Australia
  • Fig. 90 Australia market estimates and forecast, 2018 - 2030
  • Fig. 91 South Korea
  • Fig. 92 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 93 Thailand
  • Fig. 94 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 97 Brazil
  • Fig. 98 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 99 Mexico
  • Fig. 100 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 105 Saudi Arabia
  • Fig. 106 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 107 South Africa
  • Fig. 108 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 113 Participant categorization- nasal drug delivery technology market
  • Fig. 114 Market share of key market players- nasal drug delivery technology market
目次
Product Code: GVR-2-68038-740-7

Nasal Drug Delivery Technology Market Growth & Trends:

The global nasal drug delivery technology market was valued at USD 127.12 billion in 2022, expanding at a CAGR of 7.45% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing awareness regarding nasal products is one of the major factors driving the market.

The growing geriatric population is expected to positively drive the overall market. In 2020, there were 727 million people worldwide who are 65 years of age or older, according to a report by the United Nations Department of Economic and Social Affairs. The number of elderly people worldwide is expected to depict more than double growth during the next three decades, reaching over 1.5 billion in 2050. Between 2020 and 2050, the geriatric population is expected to grow in size across the nation. Globally, it is anticipated that the percentage of people 65 and older will rise from 9.3% in 2020 to almost 16.0% in 2050.

Moreover, increasing patient preference for nasal products owing to their efficacy and easy administration is anticipated to fuel the nasal drug delivery systems market growth. For instance, in February 2021, Nanoform Finland and Herantis announced their agreement on nasal drug delivery to the brain by creating a non-exclusive agreement for formulation proof of concept initiatives.

Additionally, the nasal drug delivery method is widely used to treat brain disorders as it offers a route for systemic circulation of drugs, low bioavailability, fast absorption, and desirable action. In this respect, nasal drug delivery could serve as an attractive non-invasive delivery method for CNS drugs. Moreover, nasal delivery of substances such as peptoids, raltitrexed, 5-fluorouracil telomerase inhibitors, and methotrexate has been shown to reduce brain tumors and increase survival in animal models.

Nasal Drug Delivery Technology Market Report Highlights:

  • Based on dosage form, the nasal spray segment held the largest revenue share in 2022 owing to the increasing incidence of infections and allergic rhinitis and growing demand for generic nasal spray drugs
  • By container type, the non-pressurized containers segment dominated the market in 2022. Nasal drops, nasal powder, and nasal gel usually come in these containers. Growing demand for related products is expected to propel the segment growth over the forecast period
  • In terms of therapeutic application, the rhinitis segment held the largest share in 2022 due to the availability of related products for its treatment
  • By distribution channel, the retail pharmacies segment accounted for the largest share in 2022 owing to easy availability and convenience
  • North America held the largest market share in 2022 owing to the rising prevalence of asthma and chronic obstructive pulmonary disease and the widespread usage of early treatment measures

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Dosage Form
    • 1.1.2 Container Type
    • 1.1.3 Therapeutic Application
    • 1.1.3 Distribution Channel
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.3 Data for Primary Interviews in Europe
      • 1.3.5.4 Data for Primary Interviews in APAC
      • 1.3.5.6 Data for Primary Interviews in Latin America
      • 1.3.5.8 Data for Primary Interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Nasal Drug Delivery Technology Market Variables, Trends & Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Rising patient preference for nasal drug delivery
      • 3.2.1.2 Growing incidence of chronic diseases
      • 3.2.1.3 Increasing adoption of self-administration practices
      • 3.2.1.4 Development of off-patent drugs for respiratory care
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Complications associated with the overuse of nasal sprays
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Nasal Drug Delivery Technology: Market Analysis Tools
    • 3.3.1 SWOT Analysis by PESTEL
    • 3.3.2 Industry Analysis - Porter's Five Forces
  • 3.4 Impact of COVID-19
    • 3.4.1 COVID-19 Impact analysis
    • 3.4.2 Impact on market players

Chapter 4 Nasal Drug Delivery Technology Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Billion)

  • 4.1 Definitions and Scope
  • 4.2 Dosage Form Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Nasal Drug Delivery Technology Market by Dosage Form
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1 Nasal Spray
      • 4.5.1.1 Nasal Spray Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.2 Nasal Drop
      • 4.5.2.1 Nasal Drop Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.3 Nasal Gel
      • 4.5.3.1 Nasal Gel Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.4 Nasal Powder
      • 4.5.4.1 Nasal Powder Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 5 Nasal Drug Delivery Technology Market: Segment Analysis, By Container Type, 2018 - 2030 (USD Billion)

  • 5.1 Definitions and Scope
  • 5.2 Container Type Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Nasal Drug Delivery Technology Market by Container Type
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1 Pressurized Containers
      • 5.5.1.1 Pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 5.5.2 Non-pressurized Containers
      • 5.5.2.1 Non-pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 6 Nasal Drug Delivery Technology Market: Segment Analysis, By Therapeutic Application, 2018 - 2030 (USD Billion)

  • 6.1 Definitions and Scope
  • 6.2 Therapeutic Application Market Share Analysis
  • 6.3 Segment Dashboard
  • 6.4 Nasal Drug Delivery Technology Market by Therapeutic Application
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1 Nasal Congestion
      • 6.5.1.1 Nasal Congestion Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.2 Rhinitis
      • 6.5.2.1 Rhinitis Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.3 Asthma
      • 6.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.4 Others
      • 6.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 7 Nasal Drug Delivery Technology Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Billion)

  • 7.1 Definitions and Scope
  • 7.2 Distribution Channel Market Share Analysis
  • 7.3 Segment Dashboard
  • 7.4 Nasal Drug Delivery Technology Market by Distribution Channel
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1 Hospital Pharmacies
      • 7.5.1.1 Hospital Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.2 Retail Pharmacies
      • 7.5.2.1 Retail Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.3 Online Pharmacies
      • 7.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.4 Others
      • 7.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 8 Nasal Drug Delivery Technology Market: Regional Market Analysis, 2018 - 2030 (USD Billion)

  • 8.1 Regional Market Dashboard
  • 8.2 Definitions and Scope
  • 8.3 Regional Market Share Analysis
  • 8.4 North America
    • 8.4.1 North America market estimates and forecast, 2018 - 2030
    • 8.4.2 U.S.
      • 8.4.2.1 U.S. market estimates and forecast, 2018 - 2030
    • 8.4.3 Canada
      • 8.4.3.1 Canada market estimates and forecast, 2018 - 2030
  • 8.5 Europe
    • 8.5.1 Europe market estimates and forecast, 2018 - 2030
    • 8.5.2 U.K.
      • 8.5.2.1 U.K. market estimates and forecast, 2018 - 2030
    • 8.5.3 Germany
      • 8.5.3.1 Germany market estimates and forecast, 2018 - 2030
    • 8.5.4 France
      • 8.5.4.1 France market estimates and forecast, 2018 - 2030
    • 8.5.5 Italy
      • 8.5.5.1 Italy market estimates and forecast, 2018 - 2030
    • 8.5.6 Spain
      • 8.5.6.1 Spain market estimates and forecast, 2018 - 2030
    • 8.5.7 Sweden
      • 8.5.7.1 Sweden market estimates and forecast, 2018 - 2030
    • 8.5.8 Denmark
      • 8.5.8.1 Denmark market estimates and forecast, 2018 - 2030
    • 8.5.9 Norway
      • 8.5.9.1 Norway market estimates and forecast, 2018 - 2030
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific market estimates and forecast, 2018 - 2030
    • 8.6.2 Japan
      • 8.6.2.1 Japan market estimates and forecast, 2018 - 2030
    • 8.6.3 China
      • 8.6.3.1 China market estimates and forecast, 2018 - 2030
    • 8.6.4 India
      • 8.6.4.1 India market estimates and forecast, 2018 - 2030
    • 8.6.5 Australia
      • 8.6.5.1 Australia market estimates and forecast, 2018 - 2030
    • 8.6.6 South Korea
      • 8.6.6.1 South Korea market estimates and forecast, 2018 - 2030
    • 8.6.7 Thailand
      • 8.6.7.1 Thailand market estimates and forecast, 2018 - 2030
  • 8.7 Latin America
    • 8.7.1 Latin America market estimates and forecast, 2018 - 2030
    • 8.7.2 Mexico
      • 8.7.2.1 Mexico market estimates and forecast, 2018 - 2030
    • 8.7.3 Brazil
      • 8.7.3.1 Brazil market estimates and forecast, 2018 - 2030
    • 8.7.4 Argentina
      • 8.7.4.1 Argentina market estimates and forecast, 2018 - 2030
  • 8.8 Middle East and Africa
    • 8.8.1 Middle East and Africa market estimates and forecast, 2018 - 2030
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa market estimates and forecast, 2018 - 2030
    • 8.8.3 Saudi Arabia
      • 8.8.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030
    • 8.8.4 UAE
      • 8.8.4.1 UAE market estimates and forecast, 2018 - 2030
    • 8.8.5 Kuwait
      • 8.8.5.1 Kuwait market estimates and forecast, 2018 - 2030

Chapter 9 Nasal Drug Delivery Technology Market - Competitive Analysis

  • 9.1 Kind of Competition
  • 9.2 Concentration of Market Players
  • 9.3 Company Market Share Analysis
  • 9.4 Categorization based on the Company's Vision
  • 9.5 Company Profiles
    • 9.5.1 GlaxoSmithKline PLC
      • 9.5.1.1 Company overview
      • 9.5.1.2 Financial performance
      • 9.5.1.3 Product benchmarking
      • 9.5.1.4 Strategic initiatives
    • 9.5.2 AstraZeneca PLC
      • 9.5.2.1 Company overview
      • 9.5.2.2 Financial performance
      • 9.5.2.3 Product benchmarking
      • 9.5.2.4 Strategic initiatives
    • 9.5.3 Pfizer, Inc.
      • 9.5.3.1 Company overview
      • 9.5.3.2 Financial performance
      • 9.5.3.3 Productbenchmarking
      • 9.5.3.4 Strategic initiatives
    • 9.5.4 OptiNose, Inc.
      • 9.5.4.1 Company overview
      • 9.5.4.2 Financial performance
      • 9.5.4.3 Product benchmarking
      • 9.5.4.4 Strategic initiatives
    • 9.5.5 Becton, Dickinson and Company
      • 9.5.5.1 Company overview
      • 9.5.5.2 Financial performance
      • 9.5.5.3 Product benchmarking
      • 9.5.5.4 Strategic initiatives
    • 9.5.6 Promius Pharma, LLC
      • 9.5.6.1 Company overview
      • 9.5.6.2 Financial performance
      • 9.5.6.3 Product benchmarking
      • 9.5.6.4 Strategic initiatives
    • 9.5.7 Cadila Pharmaceuticals Ltd.
      • 9.5.7.1 Company overview
      • 9.5.7.2 Financial performance
      • 9.5.7.3 Product benchmarking
      • 9.5.7.4 Strategic initiatives
    • 9.5.8 B.F. Ascher & Company, Inc.
      • 9.5.8.1 Company overview
      • 9.5.8.2 Financial performance
      • 9.5.8.3 Product benchmarking
      • 9.5.8.4 Strategic initiatives
    • 9.5.9 PendoPharm, Inc.
      • 9.5.9.1 Company overview
      • 9.5.9.2 Financial performance
      • 9.5.9.3 Product benchmarking
      • 9.5.9.4 Strategic initiatives
    • 9.5.10 Douglas Pharmaceuticals Ltd.
      • 9.5.10.1 Company overview
      • 9.5.10.2 Financial performance
      • 9.5.10.3 Product benchmarking
      • 9.5.10.4 Strategic initiatives
    • 9.5.11 ENT Technologies Pty. Ltd.
      • 9.5.11.1 Company overview
      • 9.5.11.2 Financial performance
      • 9.5.11.3 Product benchmarking
      • 9.5.11.4 Strategic initiatives
    • 9.5.12 ENT Technologies Pty. Ltd.
      • 9.5.12.1 Company overview
      • 9.5.12.2 Financial performance
      • 9.5.12.3 Product benchmarking
      • 9.5.12.4 Strategic initiatives